TIAA CREF Investment Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

TIAA CREF Investment Management’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-24,885	Closed	-$178K	–	3274
2015 Q2	$178K	Sell	24,885 -71,158	-74%	-$535K	﹤0.01%	3123
2015 Q1	$813K	Hold	96,043	–	–	﹤0.01%	2730
2014 Q4	$894K	Sell	96,043 -1,368	-1%	-$11.9K	﹤0.01%	2717
2014 Q3	$811K	Sell	97,411 -3,555	-4%	-$32.9K	﹤0.01%	2761
2014 Q2	$1.17M	Buy	100,966 +38,861	+63%	+$399K	﹤0.01%	2628
2014 Q1	$787K	Sell	62,105 -520	-0.8%	-$6.72K	﹤0.01%	2770
2013 Q4	$678K	Hold	62,625	–	–	﹤0.01%	2869
2013 Q3	$775K	Buy	62,625 +592	+1%	+$8.19K	﹤0.01%	2762
2013 Q2	$828K	Buy	+62,033	New	+$798K	﹤0.01%	2699

Other funds holding DSCI

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TIAA CREF Investment Management's DSCI Position: Q3 2015 in Review

TIAA CREF Investment Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q3 2015, closing a stake of 24,885 shares — an estimated $178K sold.

TIAA CREF Investment Management first reported a position in DSCI in Q2 2013 and held it in 9 quarters. The position peaked at $1.17M in Q2 2014. 55 funds tracked by Wall St. Rank hold DSCI as of Q3 2015.

TIAA CREF Investment Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q3 2015 after selling out during the quarter.
TIAA CREF Investment Management sold 24,885 Derma Sciences, Inc. Common Stock (DE) shares in Q3 2015, an estimated $178K.
TIAA CREF Investment Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 9 quarters.
TIAA CREF Investment Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $1.17M in Q2 2014.
55 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q3 2015.

Based on TIAA CREF Investment Management's 13F filing for Q3 2015, filed 13 Nov 2015.